|
humans |
112 |
|
nasopharyngeal carcinoma |
98 |
|
female |
85 |
|
chinese |
81 |
|
male |
80 |
|
adult |
67 |
|
adolescent |
64 |
|
children |
57 |
|
covid-19 |
56 |
|
child |
48 |
|
treatment outcome |
47 |
|
middle aged |
44 |
|
medical sciences |
43 |
|
radiotherapy |
43 |
|
prognosis |
42 |
|
quality of life |
42 |
|
hong kong |
41 |
|
survival |
40 |
|
magnetic resonance imaging |
39 |
|
adolescent idiopathic scoliosis |
38 |
|
incidence |
38 |
|
chemotherapy |
37 |
|
child, preschool |
37 |
|
epidemiology |
36 |
|
infant |
34 |
|
randomized controlled trial |
34 |
|
animals |
32 |
|
retrospective studies |
32 |
|
aged |
29 |
|
cancer |
29 |
|
follow-up studies |
28 |
|
hong kong - epidemiology |
28 |
|
efficacy |
26 |
|
lung cancer |
26 |
|
risk factors |
23 |
|
survival rate |
23 |
|
time factors |
23 |
|
age factors |
22 |
|
immunotherapy |
21 |
|
meta-analysis |
21 |
|
tumor microenvironment |
21 |
|
chemoradiotherapy |
20 |
|
genetic susceptibility |
20 |
|
mice |
20 |
|
oncology |
20 |
|
outcome |
20 |
|
whole-exome sequencing |
20 |
|
bone marrow transplantation |
19 |
|
china |
19 |
|
genotype |
19 |
|
graft survival |
19 |
|
metastasis |
19 |
|
nasopharyngeal cancer |
19 |
|
prevalence |
19 |
|
aged, 80 and over |
18 |
|
controlled study |
18 |
|
intervertebral disc |
18 |
|
mri |
18 |
|
scoliosis |
18 |
|
analysis of variance |
17 |
|
asian continental ancestry group |
17 |
|
late toxicity |
17 |
|
low back pain |
17 |
|
mesenchymal stem cells |
17 |
|
phenotype |
17 |
|
radiation therapy |
17 |
|
surgery |
17 |
|
cadaver |
16 |
|
child psychosocial problems |
16 |
|
coronavirus |
16 |
|
cytokines |
16 |
|
degeneration |
16 |
|
healthcare workers |
16 |
|
home confinement |
16 |
|
hospital policies |
16 |
|
magnetic resonance imaging - methods |
16 |
|
perceived stress |
16 |
|
psychological wellbeing |
16 |
|
school closure |
16 |
|
alleles |
15 |
|
cells, cultured |
15 |
|
collagen |
15 |
|
fatigue |
15 |
|
human |
15 |
|
infants |
15 |
|
inflammation |
15 |
|
lumbar |
15 |
|
mortality |
15 |
|
nasopharyngeal carcinoma (npc) |
15 |
|
nomogram |
15 |
|
prognostication |
15 |
|
prospective studies |
15 |
|
survival analysis |
15 |
|
biocompatibility |
14 |
|
biomechanics |
14 |
|
combined modality therapy |
14 |
|
epstein-barr virus |
14 |
|
genetic association |
14 |
|
genetics |
14 |
|
materials testing |
14 |
|
npc |
14 |
|
prognostic factors |
14 |
|
single nucleotide polymorphism |
14 |
|
traumatic brain injury |
14 |
|
aerobic exercise |
13 |
|
bacteria |
13 |
|
bile duct atresia |
13 |
|
body weight |
13 |
|
cancer susceptibility genes |
13 |
|
capecitabine |
13 |
|
cartilage |
13 |
|
case-control study |
13 |
|
china - epidemiology |
13 |
|
chromosome 10q |
13 |
|
cognition |
13 |
|
complication |
13 |
|
early onset scoliosis |
13 |
|
early-age onset |
13 |
|
fatal outcome |
13 |
|
functional outcome |
13 |
|
gene function |
13 |
|
gene identification |
13 |
|
gene locus |
13 |
|
immunoglobulin |
13 |
|
immunohistochemistry |
13 |
|
imrt |
13 |
|
lymphocyte subsets |
13 |
|
major clinical study |
13 |
|
mst1r |
13 |
|
priority journal |
13 |
|
risk factor |
13 |
|
safety |
13 |
|
sars |
13 |
|
spine |
13 |
|
strontium |
13 |
|
survival prediction |
13 |
|
systematic review |
13 |
|
targeted therapy |
13 |
|
tissue engineering - methods |
13 |
|
adolescents |
12 |
|
animal model |
12 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
12 |
|
apobec-mediated signature |
12 |
|
apoptosis |
12 |
|
asparaginase |
12 |
|
bioactive bone cement |
12 |
|
case-control studies |
12 |
|
convalescence |
12 |
|
false positive |
12 |
|
gene expression regulation, neoplastic |
12 |
|
gwa |
12 |
|
intensity-modulated radiation therapy |
12 |
|
intensity-modulated radiotherapy |
12 |
|
kawasaki disease |
12 |
|
management |
12 |
|
mcgr |
12 |
|
microscopy, electron, scanning |
12 |
|
mind-body intervention |
12 |
|
nf-κb signaling |
12 |
|
non-small cell lung cancer |
12 |
|
osteoporosis |
12 |
|
pediatric |
12 |
|
pediatric liver transplantation |
12 |
|
pilot projects |
12 |
|
promoter hypermethylation |
12 |
|
ret |
12 |
|
sars-cov-2 |
12 |
|
sars-cov-2 rbd igg |
12 |
|
serology |
12 |
|
severity of illness index |
12 |
|
sex factors |
12 |
|
somatic mutation landscape |
12 |
|
t cell response |
12 |
|
tomography, x-ray computed |
12 |
|
transplantation |
12 |
|
treatment |
12 |
|
young adult |
12 |
|
accelerated fractionation |
11 |
|
allergy |
11 |
|
biomarker |
11 |
|
cell differentiation |
11 |
|
chemicals and cas registry numbers |
11 |
|
complications |
11 |
|
disease progression |
11 |
|
disease-free survival |
11 |
|
dna methylation |
11 |
|
esophageal squamous cell carcinoma (escc) |
11 |
|
in situ hybridization, fluorescence |
11 |
|
infant, newborn |
11 |
|
intervertebral disc - pathology |
11 |
|
intraoperative complications - epidemiology |
11 |
|
leukemia |
11 |
|
liver transplantation - statistics & numerical data |
11 |
|
machine learning |
11 |
|
mesenchymal stem cell |
11 |
|
neoplasm staging |
11 |
|
neurotoxicity |
11 |
|
nickel |
11 |
|
nidogen-2 (nid2) |
11 |
|
organ size |
11 |
|
physical activity |
11 |
|
plasma ebv dna |
11 |
|
psychometrics |
11 |
|
questionnaires |
11 |
|
recursive partitioning analysis |
11 |
|
skeletal maturity |
11 |
|
staging |
11 |
|
tissue engineering |
11 |
|
titanium |
11 |
|
asia |
10 |
|
asian continental ancestry group - genetics |
10 |
|
biocompatible materials |
10 |
|
brain microstructure |
10 |
|
classification |
10 |
|
cognitive behavioral therapy |
10 |
|
computer applications |
10 |
|
cross-sectional studies |
10 |
|
diffusion kurtosis imaging |
10 |
|
disc |
10 |
|
disc degeneration |
10 |
|
enterococcus faecalis |
10 |
|
family caregiver |
10 |
|
health-related quality of life |
10 |
|
human leukocyte antigens |
10 |
|
hypersensitivity |
10 |
|
immunosuppressive agents - therapeutic use |
10 |
|
induction chemotherapy |
10 |
|
intervertebral disc degeneration |
10 |
|
intervertebral disk |
10 |
|
intracranial germ cell tumor |
10 |
|
liver diseases - surgery |
10 |
|
liver transplantation - methods - statistics and numerical data |
10 |
|
living donors - supply and distribution |
10 |
|
lumbar disc degeneration |
10 |
|
lumbar vertebrae - pathology |
10 |
|
magnetically controlled growing rod |
10 |
|
medical sciences medical sciences |
10 |
|
mesenchymal stem cell transplantation |
10 |
|
milk |
10 |
|
molecular tumour board |
10 |
|
neurotoxicity syndromes |
10 |
|
next-generation sequencing |
10 |
|
nucleus pulposus |
10 |
|
precision oncology |
10 |
|
predictive value of tests |
10 |
|
rabbits |
10 |
|
recurrent |
10 |
|
scarce deceased donors |
10 |
|
sensitivity |
10 |
|
sequence-directed therapy |
10 |
|
t-lymphocytes |
10 |
|
tissue donors - supply and distribution |
10 |
|
25-hydroxyvitamin d |
9 |
|
adc |
9 |
|
age-stratified |
9 |
|
autoimmune disease |
9 |
|
bioactivity |
9 |
|
bone and bones - physiology |
9 |
|
chi-square distribution |
9 |
|
chromatin accessibility |
9 |
|
chromosome 6p |
9 |
|
clinical effectiveness |
9 |
|
cognitive behavioural therapy |
9 |
|
conservative treatment |
9 |
|
corrosion |
9 |
|
dce-mri |
9 |
|
degenerative disc disease |
9 |
|
diagnosis, differential |
9 |
|
dietary fiber |
9 |
|
diffusion |
9 |
|
drug therapy, combination |
9 |
|
dw-mri |
9 |
|
ebv |
9 |
|
endodontics |
9 |
|
family caregivers |
9 |
|
fresh vegetable and fruit |
9 |
|
genetic epidemiology |
9 |
|
genetic variant |
9 |
|
genome-wide association |
9 |
|
germ cells |
9 |
|
glycosaminoglycans - metabolism |
9 |
|
hematopoietic stem cell transplantation |
9 |
|
hospitals, university |
9 |
|
host-virus interaction |
9 |
|
illumina humanmethylation450 |
9 |
|
infection |
9 |
|
leucocyte telomere length |
9 |
|
life-course |
9 |
|
liver diseases - epidemiology |
9 |
|
liver function tests |
9 |
|
local recurrence |
9 |
|
mechanical properties |
9 |
|
methylome |
9 |
|
mrs |
9 |
|
multiple imputation |
9 |
|
mutation |
9 |
|
neuroblastoma |
9 |
|
nickel - chemistry |
9 |
|
npc risk |
9 |
|
nuclear family |
9 |
|
orthopedics and traumatology |
9 |
|
osteoblasts |
9 |
|
postoperative complications - epidemiology |
9 |
|
preserved food |
9 |
|
prevention |
9 |
|
prognostic marker |
9 |
|
recurrence |
9 |
|
reirradiation |
9 |
|
reliability |
9 |
|
reoperation |
9 |
|
saliva |
9 |
|
salvage treatment |
9 |
|
signal transduction - drug effects |
9 |
|
soybean product |
9 |
|
stage classification |
9 |
|
stress, mechanical |
9 |
|
strontium-containing hydroxyapatite |
9 |
|
surface modification |
9 |
|
telomere biology |
9 |
|
titanium - chemistry |
9 |
|
toxicities |
9 |
|
travel history |
9 |
|
ultraviolet radiation |
9 |
|
vaccine |
9 |
|
vitamin d |
9 |
|
vitamin d deficiency |
9 |
|
whole-genome bisulfite sequencing |
9 |
|
abdominal pain |
8 |
|
adolescence |
8 |
|
adult spinal deformity |
8 |
|
alkaline phosphatase - metabolism |
8 |
|
allelic imbalance |
8 |
|
antimicrobial resistance |
8 |
|
biliary atresia - complications - surgery |
8 |
|
bintrafusp alfa |
8 |
|
bnt162b2 mrna covid-19 vaccines |
8 |
|
breast cancer |
8 |
|
case report |
8 |
|
cell culture techniques - methods |
8 |
|
cell proliferation - drug effects |
8 |
|
childhood cancer |
8 |
|
childhood cancer survivors |
8 |
|
chinese children |
8 |
|
chromosomes, human, pair 6 - genetics |
8 |
|
chronic |
8 |
|
cigarette smoking |
8 |
|
coculture techniques |
8 |
|
cognitive function |
8 |
|
complications of liver transplantation |
8 |
|
correlative biomarkers |
8 |
|
curve progression |
8 |
|
cyclosporine - therapeutic use |
8 |
|
development |
8 |
|
diarrhoea |
8 |
|
disease models, animal |
8 |
|
dose-response relation |
8 |
|
drug resistance |
8 |
|
equipment design |
8 |
|
fibrosis |
8 |
|
flexibility |
8 |
|
gene frequency |
8 |
|
gene therapy |
8 |
|
genetic predisposition to disease |
8 |
|
head and neck cancer |
8 |
|
histology |
8 |
|
hypercytokinemia |
8 |
|
innate immunity |
8 |
|
intervertebral |
8 |
|
kir genetics |
8 |
|
liver diseases - etiology - surgery |
8 |
|
liver transplantation - adverse effects - statistics & numerical data |
8 |
|
liver transplantation - contraindications - methods - mortality - statistics & numerical data |
8 |
|
liver transplantation - methods |
8 |
|
living donor liver transplant |
8 |
|
living donors |
8 |
|
living-related liver transplantation |
8 |
|
lumbar vertebrae |
8 |
|
magnetically controlled growing rods |
8 |
|
meningitis |
8 |
|
mice, transgenic |
8 |
|
microspheres |
8 |
|
microsurgery |
8 |
|
nasopharyngeal neoplasms - genetics |
8 |
|
nasopharyngeal neoplasms - metabolism - pathology |
8 |
|
nasopharyngectomy |
8 |
|
neonates |
8 |
|
nickel titanium |
8 |
|
nk cells |
8 |
|
odds ratio |
8 |
|
osteogenesis |
8 |
|
paediatric gastroenterology |
8 |
|
patient selection |
8 |
|
pediatric liver transplant |
8 |
|
plasma immersion ion implantation |
8 |
|
portoenterostomy, hepatic |
8 |
|
postoperative complications - classification - epidemiology |
8 |
|
radiotherapy dosage |
8 |
|
recurrent or metastatic nasopharyngeal cancer |
8 |
|
reduced-size liver transplant |
8 |
|
reduced-size liver transplantation |
8 |
|
screening |
8 |
|
self-esteem |
8 |
|
sensitivity and specificity |
8 |
|
smoking cessation |
8 |
|
spinal |
8 |
|
standard of care |
8 |
|
stem cell |
8 |
|
survival outcome |
8 |
|
tert |
8 |
|
thalassemia |
8 |
|
tissue donors |
8 |
|
tissue donors - statistics & numerical data |
8 |
|
toxicity |
8 |
|
transcription factors - genetics |
8 |
|
translation to patients |
8 |
|
vaccine-related myocarditis |
8 |
|
validity |
8 |
|
weight-bearing |
8 |
|
activities of daily living |
7 |
|
advanced cancer |
7 |
|
advanced lung cancer |
7 |
|
als |
7 |
|
anastomosis, roux-en-y |
7 |
|
anastomosis, surgical - methods |
7 |
|
animal experiment |
7 |
|
animal tissue |
7 |
|
bile duct diseases - etiology |
7 |
|
bile ducts - blood supply - surgery |
7 |
|
biliary atresia |
7 |
|
bilirubin - blood |
7 |
|
blm |
7 |
|
bone/joint abnormalities |
7 |
|
brain tumors |
7 |
|
cadaveric transplantation |
7 |
|
cartilage diseases - genetics |
7 |
|
causality |
7 |
|
ccdc170 |
7 |
|
cell cycle |
7 |
|
cell proliferation |
7 |
|
cell therapy |
7 |
|
cell viability |
7 |
|
cervical myelopathy |
7 |
|
cisplatin |
7 |
|
clinical article |
7 |
|
clinical outcome |
7 |
|
coated materials, biocompatible - chemistry |
7 |
|
cohort studies |
7 |
|
col9a2 |
7 |
|
comorbidity |
7 |
|
compressive strength |
7 |
|
concurrent chemotherapy |
7 |
|
cord blood transplantation |
7 |
|
corrosion resistance |
7 |
|
databases, genetic |
7 |
|
debridement |
7 |
|
decellularization |
7 |
|
developmental spinal stenosis |
7 |
|
directed differentiation |
7 |
|
dna dsb repair |
7 |
|
dose-response relationship, radiation |
7 |
|
durapatite |
7 |
|
dyspnea |
7 |
|
early childhood exposure |
7 |
|
early onset scoliosis-24 questionnaire |
7 |
|
eosq-24 |
7 |
|
eq-5d-5l |
7 |
|
extracellular matrix proteins - chemistry - genetics |
7 |
|
extracellular matrix proteins - genetics - physiology |
7 |
|
familial npc |
7 |
|
family financial pressure |
7 |
|
fracture |
7 |
|
gene library |
7 |
|
genetic correlation |
7 |
|
genome scan |
7 |
|
genomic adjusted radiation dose |
7 |
|
genotype-phenotype correlations |
7 |
|
glioma |
7 |
|
graft rejection |
7 |
|
head and neck neoplasms |
7 |
|
healing |
7 |
|
hepatic artery - surgery |
7 |
|
hepatitis - surgery |
7 |
|
histocompatibility |
7 |
|
human induced pluripotent stem cells |
7 |
|
idiopathic scoliosis |
7 |
|
imaging |
7 |
|
immune thrombocytopenia |
7 |
|
immunological profiles |
7 |
|
immunophenotyping |
7 |
|
interface |
7 |
|
intervertebral disc disease |
7 |
|
intervertebral disk displacement - complications - epidemiology - genetics |
7 |
|
karyotyping |
7 |
|
linkage analysis |
7 |
|
liver diseases - congenital - mortality - surgery |
7 |
|
liver diseases - epidemiology - surgery |
7 |
|
liver failure - surgery |
7 |
|
liver transplantation |
7 |
|
liver transplantation - adverse effects - methods - mortality |
7 |
|
liver transplantation - adverse effects - methods - pathology - statistics & numerical data |
7 |
|
liver transplantation - methods - physiology |
7 |
|
living donors - classification |
7 |
|
logistic models |
7 |
|
macrophage |
7 |
|
magnesium |
7 |
|
mapping complex traits |
7 |
|
matrix metalloproteinase 1 - genetics |
7 |
|
mesenchymal stem cell transplantation - methods |
7 |
|
mesenchymal stem cells (mscs) |
7 |
|
microrna |
7 |
|
microvascular anastomosis |
7 |
|
natural history |
7 |
|
next generation sequencing |
7 |
|
nhej |
7 |
|
nitinol |
7 |
|
notochord-like cells (ncls) |
7 |
|
nucleus pulposus (np)-like cells |
7 |
|
nursing |
7 |
|
olt |
7 |
|
oncology medical sciences |
7 |
|
osteoarthritis |
7 |
|
osteoblast |
7 |
|
osteoblasts - cytology |
7 |
|
pain |
7 |
|
pathway associations |
7 |
|
patient satisfaction |
7 |
|
pediatrics |
7 |
|
personalize |
7 |
|
pleiotropy |
7 |
|
polygenic score |
7 |
|
polymorphism, single nucleotide |
7 |
|
post-transplantation lymphoproliferative disease |
7 |
|
postoperative complications |
7 |
|
postoperative complications - prevention & control - surgery |
7 |
|
primitive neuroectodermal tumor |
7 |
|
promoter regions, genetic |
7 |
|
prostheses and implants |
7 |
|
proteoglycan |
7 |
|
pyrophosphatases - genetics - physiology |
7 |
|
rabbit |
7 |
|
radiation dose |
7 |
|
radiograph |
7 |
|
radiomics |
7 |
|
rats |
7 |
|
recovery of function |
7 |
|
reference values |
7 |
|
regeneration |
7 |
|
registries |
7 |
|
reverse transcriptase polymerase chain reaction |
7 |
|
risk assessment |
7 |
|
rod |
7 |
|
rotation |
7 |
|
scoliosis screening |
7 |
|
sequence |
7 |
|
solid organ transplantation |
7 |
|
spinal diseases - genetics |
7 |
|
spinal fusion |
7 |
|
stents |
7 |
|
superelastic |
7 |
|
survivorship |
7 |
|
tai chi |
7 |
|
telomere |
7 |
|
telomere length |
7 |
|
thrombosis - prevention & control |
7 |
|
trp2 |
7 |
|
ute |
7 |
|
vascular surgical procedures - methods |
7 |
|
vertebral disk displumbar vertebrae |
7 |
|
viral load |
7 |
|
25(oh)d |
6 |
|
adeno-associated virus |
6 |
|
adenovirus |
6 |
|
adherens junctions - metabolism |
6 |
|
administration, oral |
6 |
|
aging |
6 |
|
alginate |
6 |
|
alpha b-crystallin |
6 |
|
anaphylaxis |
6 |
|
anti-angiogenesis |
6 |
|
asthma |
6 |
|
atomic force microscope |
6 |
|
back pain - diagnosis - epidemiology |
6 |
|
basal ganglia |
6 |
|
base sequence |
6 |
|
bioluminescent bacteria |
6 |
|
biomarkers |
6 |
|
blotting, western |
6 |
|
bone |
6 |
|
bone cements - metabolism |
6 |
|
bone marrow aspiration |
6 |
|
bone marrow cells - cytology |
6 |
|
bone morphogenetic protein-2 |
6 |
|
breast neoplasms |
6 |
|
cadherins - metabolism |
6 |
|
cancer immunosuppression |
6 |
|
cancer-related fatigue |
6 |
|
carcinogenesis |
6 |
|
carcinoma |
6 |
|
carcinoma - metabolism - pathology |
6 |
|
ccrk |
6 |
|
cell cycle - physiology |
6 |
|
cell transplantation |
6 |
|
cerebrolysin |
6 |
|
cfu-f |
6 |
|
challenge |
6 |
|
chemotherapy, adjuvant |
6 |
|
chondrocytes - cytology - metabolism |
6 |
|
clustering |
6 |
|
col9a3 |
6 |
|
collagen fibril |
6 |
|
collagen type ix - genetics |
6 |
|
colorectal cancer |
6 |
|
colorectal neoplasms - etiology |
6 |
|
conservation |
6 |
|
core-shell microspheres |
6 |
|
cxcl8 |
6 |
|
cxcr2 |
6 |
|
cyclin-dependent kinases - physiology |
6 |
|
degenerative |
6 |
|
depressive symptoms |
6 |
|
developmental |
6 |
|
diffusion tensor imaging |
6 |
|
dnmt1 |
6 |
|
dosimetric predictors |
6 |
|
double-negative b cells |
6 |
|
drug |
6 |
|
durapatite - metabolism |
6 |
|
e-cadherin |
6 |
|
early diagnosis |
6 |
|
early-onset scoliosis |
6 |
|
elderly |
6 |
|
electromyography |
6 |
|
estrogen receptors (ers) |
6 |
|
extracellular vesicle |
6 |
|
fibrillar collagens - chemistry - ultrastructure |
6 |
|
fusion |
6 |
|
gc gene |
6 |
|
gene expression |
6 |
|
genetic variation - genetics |
6 |
|
gwas |
6 |
|
half-life clearance |
6 |
|
hkuot-s2 protein |
6 |
|
human intervertebral disc |
6 |
|
hydrocephalus |
6 |
|
hydroxyapatite |
6 |
|
hyperinsulinism |
6 |
|
hypertrophy |
6 |
|
hypoglycaemia |
6 |
|
hypothyroidism |
6 |
|
innate immune response |
6 |
|
instrumentation |
6 |
|
intervertebral disc displacement - diagnosis - epidemiology |
6 |
|
intervertebral disc displacement - epidemiology - genetics |
6 |
|
intervertebral disc herniation |
6 |
|
intervertebral disk - chemistry |
6 |
|
irrigation |
6 |
|
laminoplasty |
6 |
|
latent transforming growth factor β binding protein 2 (ltbp-2) |
6 |
|
ligamentum flavum |
6 |
|
lipoteichoic acid |
6 |
|
lumbar vertebrae - pathology - radiography |
6 |
|
magnetics |
6 |
|
materials testing - methods |
6 |
|
mechanical characterization |
6 |
|
medulloblastoma |
6 |
|
mesenchymal stem cells - cytology - drug effects |
6 |
|
mesenchymal stromal cell |
6 |
|
metastatic growth |
6 |
|
methylation |
6 |
|
mice, mutant strains |
6 |
|
microencapsulation |
6 |
|
microfluidics |
6 |
|
microscopy, electron |
6 |
|
mif |
6 |
|
molecular genetics |
6 |
|
mri-guided interventions |
6 |
|
ms‐hrm |
6 |
|
multidisciplinary |
6 |
|
nanofibers - chemistry - ultrastructure |
6 |
|
nanoindentation |
6 |
|
nanostructure |
6 |
|
neoplasm proteins - physiology |
6 |
|
neurofibromatosis |
6 |
|
niti |
6 |
|
orthopedic implants |
6 |
|
osseointegration |
6 |
|
osteoblast functions |
6 |
|
osteogenic differentiation |
6 |
|
ovariectomy (ovx) |
6 |
|
pain measurement |
6 |
|
palbociclib |
6 |
|
palliative care |
6 |
|
patient-derived xenografts |
6 |
|
pattern of failure |
6 |
|
patterns of degeneration |
6 |
|
pediatric cardiology |
6 |
|
plasma epstein–barr virus deoxyribonucleic acid |
6 |
|
platelet-rich plasma |
6 |
|
polymorphism, restriction fragment length |
6 |
|
population based study |
6 |
|
quantitative phase imaging |
6 |
|
radiotherapy, adjuvant |
6 |
|
receptors, calcitriol - genetics |
6 |
|
rehabilitation |
6 |
|
rhinitis |
6 |
|
rod slippage |
6 |
|
root canal infection |
6 |
|
saha |
6 |
|
sciatica - diagnosis - epidemiology |
6 |
|
second primary cancer |
6 |
|
self-antibacterial effect |
6 |
|
self-efficacy |
6 |
|
signaling pathways |
6 |
|
single-cell imaging |
6 |
|
single‐cell imaging |
6 |
|
snoring |
6 |
|
spinal diseases - etiology - genetics - pathology |
6 |
|
spine - radiography - surgery |
6 |
|
spring-back |
6 |
|
staging system |
6 |
|
stainless steel |
6 |
|
stenosis |
6 |
|
stereotactic neurosurgery |
6 |
|
subarachnoid hemorrhage |
6 |
|
sulforaphane |
6 |
|
surgical robotics |
6 |
|
swine |
6 |
|
tai-chi |
6 |
|
taq i |
6 |
|
taq polymerase - genetics |
6 |
|
tensile strength |
6 |
|
tnm staging |
6 |
|
translocation, genetic |
6 |
|
transplantation, homologous |
6 |
|
treatment outcomes |
6 |
|
trp3 |
6 |
|
tumor |
6 |
|
tumor cell dormancy |
6 |
|
tumor suppression |
6 |
|
tumor suppressor proteins - metabolism |
6 |
|
tumour spheres |
6 |
|
ultrafast imaging |
6 |
|
ultrasound |
6 |
|
vdr gene |
6 |
|
ventricular function |
6 |
|
vitamin d receptor |
6 |
|
vitamin d-binding protein |
6 |
|
wif1 |
6 |
|
zno nanowire |
6 |
|
β-catenin |
6 |
|
γδ-t cells |
6 |
|
3' untranslated region |
5 |
|
achilles tendon |
5 |
|
acute graft-versus-host disease |
5 |
|
adenocarcinoma - drug therapy - economics |
5 |
|
adolescent idiopathic |
5 |
|
adult progenitor cells |
5 |
|
age-related degenerative disc change |
5 |
|
aging - pathology |
5 |
|
aging - physiology |
5 |
|
alloys - chemistry - metabolism |
5 |
|
alport's syndrome |
5 |
|
amino acid |
5 |
|
antibacterial |
5 |
|
antigen expression |
5 |
|
antineoplastic combined chemotherapy protocols - administration and dosage - economics - therapeutic use |
5 |
|
arteriovenous malformation |
5 |
|
back pain |
5 |
|
beta-thalassemia - blood - immunology - therapy |
5 |
|
beta-thalassemia - genetics |
5 |
|
biglycan |
5 |
|
biocompatible materials - chemistry |
5 |
|
biodegradation, environmental |
5 |
|
biological markers |
5 |
|
biomaterials |
5 |
|
bone cements |
5 |
|
bone cements - chemical synthesis - therapeutic use |
5 |
|
bone cements - chemistry - pharmacology - standards |
5 |
|
bone cements - chemistry - toxicity |
5 |
|
bone defect repair |
5 |
|
bone formation |
5 |
|
bone mineral density |
5 |
|
bone mineral density (bmd) |
5 |
|
bone regeneration |
5 |
|
bone remodeling |
5 |
|
bone remodeling - drug effects |
5 |
|
brain mapping |
5 |
|
brain tumor |
5 |
|
breast |
5 |
|
cancer outcomes |
5 |
|
cancer site-standardized relative survival |
5 |
|
cancer survivors |
5 |
|
cancer treatment |
5 |
|
candida |
5 |
|
candidate gene approach |
5 |
|
cd55 |
5 |
|
cell adhesion - drug effects |
5 |
|
cell line |
5 |
|
cell survival |
5 |
|
central nervous system |
5 |
|
cervical spondylotic myelopathy |
5 |
|
cest |
5 |
|
cheung chau island |
5 |
|
childhood |
5 |
|
childhood lymphoma |
5 |
|
chondrocytes |
5 |
|
chromosomes, human, pair 1 - genetics |
5 |
|
chromosomes, human, pair 9 - genetics |
5 |
|
classification and regression tree |
5 |
|
classification rule |
5 |
|
clonal evolution |
5 |
|
coated materials, biocompatible - chemistry - metabolism |
5 |
|
collagen - chemistry |
5 |
|
colorectal neoplasms - drug therapy - economics |
5 |
|
complement |
5 |
|
compliance |
5 |
|
continuous |
5 |
|
cord blood |
5 |
|
cord blood stem cell |
5 |
|
cost |
5 |
|
cost of screening |
5 |
|
cranial irradiation |
5 |
|
craniopharyngioma |
5 |
|
crispr/cas9 |
5 |
|
cross-border healthcare |
5 |
|
cyto-compatibility |
5 |
|
cytotoxicity |
5 |
|
decorin |
5 |
|
deferiprone (l1) |
5 |
|
deformed threads |
5 |
|
dentin |
5 |
|
deuterium oxide |
5 |
|
deuterium oxide - diagnostic use - metabolism |
5 |
|
diagnosis |
5 |
|
differentiation |
5 |
|
diffusion magnetic resonance imaging - methods |
5 |
|
dioscorea spp protein |
5 |
|
disability |
5 |
|
distraction |
5 |
|
distraction failure mechanism |
5 |
|
dna primers |
5 |
|
dose fractionation |
5 |
|
durapatite - therapeutic use |
5 |
|
early detection |
5 |
|
embolization |
5 |
|
endplate defect |
5 |
|
esophageal leiomyoma |
5 |
|
exostoses, multiple hereditary - genetics |
5 |
|
exostosis |
5 |
|
ext2 |
5 |
|
ferritins - blood |
5 |
|
fetal blood |
5 |
|
fetal hemoglobin |
5 |
|
fetal hemoglobin - biosynthesis |
5 |
|
fetal tissue transplantation |
5 |
|
fibromodulin |
5 |
|
folinic acid |
5 |
|
fractures, spontaneous - etiology - therapy |
5 |
|
fulcrum bending radiograph |
5 |
|
functional assessment |
5 |
|
genes |
5 |
|
genetics, population |
5 |
|
genome-wide association study |
5 |
|
genomics |
5 |
|
global health |
5 |
|
glucuronidase - genetics |
5 |
|
glycosaminoglycan |
5 |
|
glycosyltransferases |
5 |
|
graft versus host disease |
5 |
|
green fluorescent proteins - metabolism |
5 |
|
hardness |
5 |
|
head and neck |
5 |
|
head and neck cancers |
5 |
|
health care costs - statistics and numerical data |
5 |
|
health economics |
5 |
|
health reform |
5 |
|
hepatectomy - methods |
5 |
|
hepatoblastoma |
5 |
|
histocompatibility testing |
5 |
|
histogram analysis |
5 |
|
histological analyses |
5 |
|
hmsc |
5 |
|
hmsc transplantation |
5 |
|
homeodomain proteins - genetics |
5 |
|
hospital authority |
5 |
|
human mesenchymal stem cells |
5 |
|
human mesenchymal stromal cells |
5 |
|
human t cell |
5 |
|
humanized mice |
5 |
|
hydroxyapatites |
5 |
|
hypoxia-inducible factor |
5 |
|
igra |
5 |
|
ilium |
5 |
|
image processing, computer-assisted |
5 |
|
imaging flow cytometry |
5 |
|
immune checkpoint inhibitors |
5 |
|
immune regulation |
5 |
|
immunomodulation |
5 |
|
in situ hybridization |
5 |
|
infusion |
5 |
|
insurance, health, reimbursement - economics |
5 |
|
intervertebral disc - metabolism |
5 |
|
intervertebral disc displacement - physiopathology - radiography |
5 |
|
intervertebral disk degeneration - classification - epidemiology - radiography |
5 |
|
intracranial germ cell tumors |
5 |
|
intrathecal |
5 |
|
iron overload |
5 |
|
kyphoplasty |
5 |
|
kyphosis - radiography - surgery |
5 |
|
label-free biophysical phenotyping |
5 |
|
liver transplantation - immunology - methods - physiology |
5 |
|
lumbar vertebrae - metabolism |
5 |
|
lumbar vertebrae - radiography |
5 |
|
lumbosacral region |
5 |
|
lumbosacral region - pathology - radiography |
5 |
|
magnesium implant |
5 |
|
magnetic resonance spectroscopy |
5 |
|
magnets |
5 |
|
mandible |
5 |
|
mapk signaling pathways |
5 |
|
mapk7 |
5 |
|
mass screening - methods |
5 |
|
mass screening - methods - statistics and numerical data |
5 |
|
mastectomy, segmental |
5 |
|
medical records |
5 |
|
melatonin |
5 |
|
mesenchymal stem cells - cytology |
5 |
|
metallosis |
5 |
|
metastatic |
5 |
|
methotrexate |
5 |
|
metronomic |
5 |
|
micro-ct |
5 |
|
micrornas - biosynthesis - genetics |
5 |
|
mitochondria |
5 |
|
mitogen-activated protein kinase (mapk) pathway |
5 |
|
models, biological |
5 |
|
moiré |
5 |
|
mtor signaling pathway |
5 |
|
multidisciplinary management |
5 |
|
multiple osteochondromas |
5 |
|
mutations |
5 |
|
n-acetylglucosaminyltransferases - genetics |
5 |
|
nasophanrygeal carcinoma |
5 |
|
necrosis |
5 |
|
neovascularization, physiologic - drug effects |
5 |
|
network meta-analysis |
5 |
|
neurocognitive function |
5 |
|
neurosurgery |
5 |
|
nickel - analysis - chemistry |
5 |
|
nickel titanium shape memory alloys |
5 |
|
nickel-titanium alloy |
5 |
|
nucleic acid amplification |
5 |
|
oral cyclophosphamide |
5 |
|
orthopedic fixation devices |
5 |
|
orthopedic procedures - instrumentation |
5 |
|
osseointegration - drug effects |
5 |
|
osteoblast differentiation |
5 |
|
osteoblasts - cytology - drug effects |
5 |
|
osteoblasts - drug effects - metabolism - ultrastructure |
5 |
|
osteoclasts |
5 |
|
osteoconductive |
5 |
|
osteogenesis - drug effects |
5 |
|
osteoporosis - complications |
5 |
|
osteoporotic spine fracture |
5 |
|
oxaliplatin |
5 |
|
oxides - therapeutic use |
5 |
|
paraplegia |
5 |
|
pd-1/programmed death-ligand 1 |
5 |
|
pediatric oncology |
5 |
|
performance status |
5 |
|
pericardial effusion |
5 |
|
phantoms, imaging |
5 |
|
physical examination - methods - statistics and numerical data |
5 |
|
plasma surface treatment |
5 |
|
policy review |
5 |
|
polymerase chain reaction |
5 |
|
polymethyl methacrylate |
5 |
|
pooled analysis |
5 |
|
positive predictive value |
5 |
|
precision medicine |
5 |
|
precursor cell lymphoblastic leukemia-lymphoma - diagnosis - drug therapy - genetics |
5 |
|
pressure |
5 |
|
proliferation |
5 |
|
pulmonary fibrosis |
5 |
|
radiology - methods - statistics and numerical data |
5 |
|
radius |
5 |
|
rampant caries |
5 |
|
randomized |
5 |
|
ras |
5 |
|
ras proteins - genetics - metabolism |
5 |
|
rat |
5 |
|
receptor activator of nuclear factor-kappa b ligand |
5 |
|
referral and consultation |
5 |
|
remission induction |
5 |
|
renal abscess |
5 |
|
replication study |
5 |
|
retrospective cohort studies |
5 |
|
re‐irradiation |
5 |
|
risk |
5 |
|
rna, messenger - metabolism |
5 |
